Silicon AnalyticaSynopsys income statement and balance sheet
Every figure as filed with the SEC, with a link to its filing. The simplified view shows standard lines; "Show all line items" lists each line as Synopsys reports it.
Income statement
As filed with the SEC (10-K/10-Q), from XBRL data. US$ millions, except per-share amounts; shares in millions.
| Line item | Q3 FY2026To 31 Jul 202610-Q ↗ | Q2 FY2026To 30 Apr 202610-Q ↗ | Q1 FY2026To 31 Jan 202610-Q ↗ | Q4 FY2025To 31 Oct 202510-K ↗ | Q3 FY2025To 31 Jul 202510-Q ↗ |
|---|---|---|---|---|---|
| Revenue | 2,477 | 2,276 | 2,409 | 2,255c | 1,740 |
| Cost of revenue | 679 | 630 | 637 | 655c | 381 |
| Gross profit | 1,797 | 1,646 | 1,771 | 1,600c | 1,359 |
| Gross margin | 72.6% | 72.3% | 73.5% | 71.0% | 78.1% |
| Research & development | 720 | 700 | 715 | 747c | 625 |
| Selling, general & administrative | 563c | 554c | 579c | 576c | 540c |
| Operating income | 357 | 120 | 203 | 121c | 165 |
| Operating margin | 14.4% | 5.3% | 8.4% | 5.4% | 9.5% |
| Interest & other, net | 460 | 32 | 39 | 590c | 171 |
| Pre-tax income | 684 | 19 | 79 | 517c | 189 |
| Income tax | 138 | 2.4 | 14 | 68c | −53 |
| Net income | 546 | 17 | 65 | 449c | 243 |
| Net margin | 22.0% | 0.8% | 2.7% | 19.9% | 13.9% |
| Diluted EPS | 2.84 | 0.09 | 0.34 | — | 1.50 |
| Diluted shares | 192 | 192 | 191 | — | 162 |
Columns link to the filing. c Calculated by Silicon Analytica from filed figures (hover for the formula); fourth-quarter flows are fiscal year minus nine months. Margins are calculated. Fourth-quarter per-share figures are not filed separately and are left blank.
View sources (5)
- Synopsys 10-Q filed 26 Aug 2026 · accession 0000883241-26-000025
- Synopsys 10-Q filed 27 May 2026 · accession 0000883241-26-000018
- Synopsys 10-Q filed 25 Feb 2026 · accession 0000883241-26-000014
- Synopsys 10-K filed 22 Dec 2025 · accession 0000883241-25-000028
- Synopsys 10-Q filed 9 Sept 2025 · accession 0000883241-25-000024
Values: SEC XBRL company facts (data.sec.gov), refreshed 8 Nov 2026. A period's original filing is used unless a later filing restated it.
Balance sheet
As filed with the SEC (10-K/10-Q), from XBRL data. US$ millions, except per-share amounts; shares in millions.
| Line item | Q3 FY2026At 31 Jul 202610-Q ↗ | Q2 FY2026At 30 Apr 202610-Q ↗ | Q1 FY2026At 31 Jan 202610-Q ↗ | Q4 FY2025At 31 Oct 202510-K ↗ | Q3 FY2025At 31 Jul 202510-Q ↗ |
|---|---|---|---|---|---|
| Cash & short-term investments | 3,608 | 2,484 | 2,203 | 2,961 | 2,594 |
| Receivables | 1,319 | 1,267 | 1,641 | 1,505 | 1,392 |
| Inventories | 479 | 442 | 393 | 365 | 382 |
| Total current assets | 6,644 | 5,437 | 5,374 | 6,012 | 5,596 |
| Property, plant & equipment | 750 | 715 | 677 | 697 | 700 |
| Goodwill & intangibles | 38,293c | 38,729c | 39,170c | 39,579c | 40,026c |
| Total assets | 47,726 | 46,889 | 47,238 | 48,224 | 48,230 |
| Current liabilities | 4,970 | 3,791 | 3,943 | 3,722 | 3,444 |
| Long-term debt | 9,017 | 10,014 | 10,022 | 13,462 | 14,318 |
| Total liabilities | 16,575 | 16,412 | 16,690 | 19,897 | 20,616 |
| Shareholders' equity | 31,153 | 30,478 | 30,549 | 28,328 | 27,615 |
Columns link to the filing. c Calculated by Silicon Analytica from filed figures (hover for the formula); fourth-quarter flows are fiscal year minus nine months. Margins are calculated.
View sources (5)
- Synopsys 10-Q filed 26 Aug 2026 · accession 0000883241-26-000025
- Synopsys 10-Q filed 27 May 2026 · accession 0000883241-26-000018
- Synopsys 10-Q filed 25 Feb 2026 · accession 0000883241-26-000014
- Synopsys 10-K filed 22 Dec 2025 · accession 0000883241-25-000028
- Synopsys 10-Q filed 9 Sept 2025 · accession 0000883241-25-000024
Values: SEC XBRL company facts (data.sec.gov), refreshed 8 Nov 2026. A period's original filing is used unless a later filing restated it.